Fatty acid binding protein 4 down regulation drives calcification in the development of kidney stone disease
Kidney International Mar 08, 2020
Taguchi K, Chen L, Usawachintachit M, et al. - Since there is a lack of knowledge regarding the mechanism whereby obesity is associated with kidney stone formation, researchers applied a transcriptomics approach to determine the missing link between these two epidemic diseases. Using two RNA-sequencing approaches, they explored gene expression profiling of patients with nephrolithiasis: a contrast between renal papilla tissue with and without the presence of calcified Randall’s plaques (RP), and contrast between the papilla, medulla, and cortex regions from within a single recurrent stone forming kidney. Impairment of lipid metabolism in renal papilla tissue comprising RP connected to downregulation of fatty acid binding protein (FABP) 4 was shown by the overlay of these two RNA-sequencing datasets. A link between FABP4 downregulation and renal stone formation was confirmed on immunohistochemistry of human kidney specimens and in a microarray study of renal tissue from a nephrolithiasis mouse model. Overall, a crucial role of FABP4 in kidney stone formation which was previously unrecognized was revealed in this study, affording a feasible mechanism to describe the connection between nephrolithiasis and metabolic syndrome.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries